{
    "clinical_study": {
        "@rank": "166347", 
        "arm_group": [
            {
                "arm_group_label": "Male", 
                "arm_group_type": "Experimental", 
                "description": "To find out the effect site concentration of remifentanil for preventing QTc prolongation < 15 sec during intubation : Dixon's up-and-down method"
            }, 
            {
                "arm_group_label": "Female", 
                "arm_group_type": "Experimental", 
                "description": "To find out the effect site concentration of remifentanil for preventing QTc prolongation < 15 sec during intubation : Dixon's up-and-down method"
            }
        ], 
        "brief_summary": {
            "textblock": "To find out the effect site concentration of remifentanil for preventing QTc interval\n      prolongation during intubation under propofol-remifentanil anesthesia in elderly patients"
        }, 
        "brief_title": "The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation Under Propofol-remifentanil Anesthesia in Elderly Patients", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "General Surgery With Endotracheal Intubation", 
        "detailed_description": {
            "textblock": "The increase of Corrected QT (QTc) interval is associated with age. It is known that most\n      inhalation anesthetics or intravenous anesthetics can influence the QTc. In addition,\n      tracheal intubation during induction can stimulates sympathetic activity, which, as a\n      results, prolong the QTc interval. Therefore, the aim of study is to find out the effect\n      site concentration of remifentanil for preventing QTc interval prolongation during\n      intubation under propofol-remifentanil anesthesia in elderly patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2265 65 years ASA class I-II who received surgery with endotracheal intubation\n\n        Exclusion Criteria:\n\n          -  emergency surgery\n\n          -  electrocardiography abnormality\n\n          -  hypertension\n\n          -  diabetes mellitus\n\n          -  end stage renal disease\n\n          -  moderate to severe cardiac disease\n\n          -  moderate to severe liver dysfunction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720498", 
            "org_study_id": "4-2012-0581"
        }, 
        "intervention": {
            "arm_group_label": [
                "Male", 
                "Female"
            ], 
            "description": "The effect site concentration of remifentanil", 
            "intervention_name": "remifentanil", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Remifentanil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine", 
            "last_name": "So Yeon Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The effect site concentration for preventing QTc interval prolongation", 
            "safety_issue": "Yes", 
            "time_frame": "2 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720498"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Severance Hospital", 
            "investigator_full_name": "So Yeon Kim", 
            "investigator_title": "Clinical assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Severance Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Severance Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}